Lamvik J - Search Results

1

Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995.

Tangen JM, Abdelnoor M, Brinch L, Dahl IM, Lamvik J, Ly B, Nesthus I, Wisløff F. Tangen JM, et al. Among authors: lamvik j. Eur J Haematol. 1997 Aug;59(2):110-4. doi: 10.1111/j.1600-0609.1997.tb00734.x. Eur J Haematol. 1997. PMID: 9293859

2

[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96].

Lamvik J, Brinch L, Dahl IM, Sjo M, Nesthus I, Tangen JM, Berentsen S, Ly B, Shammas FV. Lamvik J, et al. Tidsskr Nor Laegeforen. 1999 May 10;119(12):1733-6. Tidsskr Nor Laegeforen. 1999. PMID: 10380587 Clinical Trial. Norwegian.

3

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen HE, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S. Lenhoff S, et al. Among authors: lamvik j. Blood. 2000 Jan 1;95(1):7-11. Blood. 2000. PMID: 10607678 Free article. Clinical Trial.

4

Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J; Nordic Myeloma Study Group. Gulbrandsen N, et al. Among authors: lamvik j. Med Oncol. 2001;18(1):65-77. doi: 10.1385/MO:18:1:65. Med Oncol. 2001. PMID: 11778972 Clinical Trial.

5

[High-dose therapy with autologous stem cell support in malignant diseases].

Wisløff F, Brinch L, Bruserud O, Dahl IM, Lamvik J. Wisløff F, et al. Among authors: lamvik j. Tidsskr Nor Laegeforen. 1994 Oct 30;114(26):3115. Tidsskr Nor Laegeforen. 1994. PMID: 7974434 Norwegian. No abstract available.

6

[Treatment with growth factors and cytokines in hematologic diseases].

Waage A, Dahl IM, Evensen SA, Holte H, Lamvik J, Sletnes K, Wisløff F. Waage A, et al. Among authors: lamvik j. Tidsskr Nor Laegeforen. 1996 May 10;116(12):1465-9. Tidsskr Nor Laegeforen. 1996. PMID: 8650635 Review. Norwegian.

7

[Treatment with high-dose cytostatic agents].

Wisløff F, Brinch L, Bruserud O, Dahl IM, Lamvik J. Wisløff F, et al. Among authors: lamvik j. Tidsskr Nor Laegeforen. 1994 Oct 30;114(26):3115-6. Tidsskr Nor Laegeforen. 1994. PMID: 7974435 Norwegian. No abstract available.

8

Acute leukemia in middle Norway 1984-88.

Lamvik J, Dybedal I, Hammerstrøm J, Waage A. Lamvik J, et al. Leuk Lymphoma. 1994 Dec;16(1-2):65-71. doi: 10.3109/10428199409114141. Leuk Lymphoma. 1994. PMID: 7696933

9

Interleukin 8 in serum in granulocytopenic patients with infections.

Waage A, Remick D, Steinshamn S, Deforge L, Lamvik J. Waage A, et al. Among authors: lamvik j. Br J Haematol. 1994 Jan;86(1):36-40. doi: 10.1111/j.1365-2141.1994.tb03249.x. Br J Haematol. 1994. PMID: 8011545

10

Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia.

Hjorth-Hansen H, Seidel C, Lamvik J, Börset M, Sundan A, Waage A. Hjorth-Hansen H, et al. Among authors: lamvik j. Eur J Haematol. 1999 Feb;62(2):129-34. doi: 10.1111/j.1600-0609.1999.tb01733.x. Eur J Haematol. 1999. PMID: 10052717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page